MLPA® - MRC Holland Kits

Please note before download:

  • Mix descriptions are only free of charge for customers with maintenance contract.
  • Don't hesitate to contact us, if there are any mix descriptions missing on this website.
  • To set up a new mix descriptions for you, still available at MRC Hollands website, please provide us the name of the mix (e.g. P002-D1), the version of the mix (e.g. Vs.02) and the date of its release.

  • To set up a new mix descriptions for you, not available at MRC Hollands website any more, please provide us the corresponding document by email or fax (+49-7822-440150-20).

Download

  • log into your SEQUENCE PILOT installation
  • go to category MLPA®
  • go to operation Mixes [master file]
  • press button [Import] and select the downloaded mme-file
  • if the corresponding mix already exists in your SEQUENE_PILOT installation you will be asked "Do you want to save the mix with a new name / lot?"; please press button [Yes] and complete the fields in the following dialogue; press button [OK] to save your entries
  • if the mix doesn't exist yet just press button [OK] in the following dialogue
MIX
VERSION
DATE
REGION
APPLICATION
DOWNLOAD
MIX
P220-B1
VERSION
Vs. 13
DATE
09-03-2016
REGION
LEPR, POMC, LEP, SIM1, MC3R, MC4R
APPLICATION
Obesity
MIX
P220-B2
VERSION
Vs. 14
DATE
12-01-2018
REGION
LEPR, POMC, LEP, SIM1, MC3R, MC4R
APPLICATION
Obesity
MIX
P221-C1
VERSION
Vs. 10
DATE
19-05-2015
REGION
AIPL1 17p13, CRB1 1q31, CRX 19q13, RPE65 1p31
APPLICATION
Leber congenital amaurosis (LCA)
MIX
P221-C1
VERSION
Vs. 11
DATE
18-08-2016
REGION
AIPL1 17p13, CRB1 1q31, CRX 19q13, RPE65 1p31
APPLICATION
Leber congenital amaurosis (LCA)
MIX
P222-A2
VERSION
Vs. 11
DATE
17-07-2015
REGION
GUCY2D 17p13.1, RDH12 14q24, RPGRIP1 14q11, CEP290 12q2
APPLICATION
Leber congenital amaurosis (LCA)
MIX
P222-B1
VERSION
Vs. 12
DATE
11-03-2016
REGION
GUCY2D 17p13.1, RDH12 14q24, RPGRIP1 14q11, CEP290 12q2
APPLICATION
Leber congenital amaurosis (LCA)
MIX
P223-B2
VERSION
Vs. 08
DATE
22-11-2013
REGION
PHEX Xp22.2, FGF23 12p13
APPLICATION
Hypophosphatemia, x-linked
MIX
P223-B3
VERSION
Vs. 09
DATE
09-05-2016
REGION
PHEX Xp22.2, FGF23 12p13
APPLICATION
Hypophosphatemia, x-linked
MIX
P224-B1
VERSION
Vs. 08
DATE
21-12-2012
REGION
PPARG 3p25.1
APPLICATION
Obesity, Diabetes mellitis type II, Familial partial lipodystrophy III, Colon cancer
MIX
P225-D2
VERSION
Vs. 21
DATE
21-03-2017
REGION
PTEN 10q23
APPLICATION
Cancer
MIX
P225-D2
VERSION
Vs. 22
DATE
07-09-2017
REGION
PTEN 10q23
APPLICATION
Cancer
MIX
P226-C1
VERSION
Vs. 18
DATE
29-02-2016
REGION
SDHD 11q23.1, SDHB 1p36.1, SDHC 1q23.3
APPLICATION
Paragangliomas (PGL)
MIX
P226-D1
VERSION
Vs. D1-02
DATE
29-06-2018
REGION
SDHD 11q23.1, SDHB 1p36.1, SDHC 1q23.3
APPLICATION
Paragangliomas (PGL)
MIX
P227-B2
VERSION
Vs. 09
DATE
13-03-2014
REGION
SerpinC1 1q25.1
APPLICATION
Antithrombin (III) deficiency
MIX
P227-B3
VERSION
Vs. 10
DATE
05-10-2017
REGION
SerpinC1 1q25.1
APPLICATION
Antithrombin (III) deficiency
MIX
P228-B1
VERSION
Vs. 08
DATE
10-07-2014
REGION
TRPS1 8q24
APPLICATION
Trichorhinophalangeal syndrome type I (TRPS1), Langer-Giedion syndrome (LGS)
MIX
P228-B2
VERSION
Vs. 09
DATE
11-10-2017
REGION
TRPS1 8q24
APPLICATION
Trichorhinophalangeal syndrome type I (TRPS1), Langer-Giedion syndrome (LGS)
MIX
P229-B2
VERSION
Vs. 14
DATE
21-01-2015
REGION
OPA1 3q28, VMD2 11q13, RDS 6p21.2
APPLICATION
Macular dystrophy
MIX
P229-B3
VERSION
Vs. 15
DATE
15-04-2015
REGION
OPA1 3q28, VMD2 11q13, RDS 6p21.2
APPLICATION
Macular dystrophy
MIX
P230-B2
VERSION
Vs. 12
DATE
24-06-2015
REGION
9p, 10p, 11p, 12p
APPLICATION
Subtelomeric screening
MIX
P230-B2
VERSION
Vs. 14
DATE
02-03-2018
REGION
9p, 10p, 11p, 12p
APPLICATION
Subtelomeric screening
MIX
P231-B1
VERSION
Vs. 07
DATE
16-10-2013
REGION
FGF10 5p13, FGFR2 10q26
APPLICATION
Autosomal dominant lacrimoauriculodentodigital (LADD)
MIX
P231-B2
VERSION
Vs. 08
DATE
21-10-2016
REGION
FGF10 5p13, FGFR2 10q26
APPLICATION
Autosomal dominant lacrimoauriculodentodigital (LADD)
MIX
P232-B1
VERSION
Vs. 05
DATE
09-10-2011
REGION
FGD1 Xp11.21
APPLICATION
Faciogenital dysplasia (FGDY), Aarskog-Scott syndrome
MIX
P232-C1
VERSION
Vs. 07
DATE
16-12-2012
REGION
FGD1 Xp11.21
APPLICATION
Faciogenital dysplasia (FGDY), Aarskog-Scott syndrome
MIX
P233-B1
VERSION
Vs. 06
DATE
16-12-2012
REGION
MID1 Xp22
APPLICATION
OPITZ syndrome
MIX
P233-B2
VERSION
Vs. 07
DATE
10-09-2013
REGION
MID1 Xp22
APPLICATION
OPITZ syndrome
MIX
P234-A2
VERSION
Vs. 09
DATE
26-03-2013
REGION
GATA4 8p23, GATA3 10p15
APPLICATION
Cardiac septal defects
MIX
P234-A3
VERSION
Vs. 11
DATE
19-09-2016
REGION
GATA4 8p23, GATA3 10p15
APPLICATION
Cardiac septal defects
MIX
P235-B2
VERSION
Vs. 05
DATE
30-01-2014
REGION
RHO 3q21.3, RP1 8q11.2, IMPDH1 7q32, PRPF31 19q13.4
APPLICATION
Retinitis Pigmentosa
MIX
P235-B3
VERSION
Vs. 06
DATE
17-06-2017
REGION
RHO 3q21.3, RP1 8q11.2, IMPDH1 7q32, PRPF31 19q13.4
APPLICATION
Retinitis Pigmentosa
MIX
P236-A3
VERSION
Vs. 14
DATE
08-03-2016
REGION
CFH, CFHR3, CFHR1, CFHR2, 1q23
APPLICATION
Age-related macular degeneration (ARMD)
MIX
P236-A3
VERSION
Vs. 15
DATE
12-07-2016
REGION
CFH, CFHR3, CFHR1, CFHR2, 1q23
APPLICATION
Age-related macular degeneration (ARMD)
MIX
P237-A1
VERSION
Vs. 03
DATE
26-08-2011
REGION
DNAH5 5p15
APPLICATION
Primary ciliary dyskinesia (PCD)
MIX
P237-B1
VERSION
Vs. 06
DATE
26-02-2013
REGION
DNAH5 5p15
APPLICATION
Primary ciliary dyskinesia (PCD)
MIX
P238-A3
VERSION
Vs. 07
DATE
08-02-2013
REGION
DNAH5 5p15
APPLICATION
Primary ciliary dyskinesia (PCD)
MIX
P238-B1
VERSION
Vs. 09
DATE
14-06-2016
REGION
DNAH5 5p15
APPLICATION
Primary ciliary dyskinesia (PCD)
MIX
P239
VERSION
Vs. 06
DATE
30-07-2009
REGION
BRCA1 region
APPLICATION
Breast cancer
MIX
P239-B1
VERSION
Vs. 09
DATE
17-12-2012
REGION
BRCA1 region
APPLICATION
Breast cancer